News

Life Vessel of Newport Beach, California and Life Vessel of Santa Fe, New Mexico offer the exclusive and proprietary BioTech L3aser Pain management treatment protocols using an FDA

The agreement provides for R&D into acne formulations based on Skinvisible’s Invisicare technology and benzoyl peroxide (BPO) manufactured by Cambrex. In addition, the two companies will share marketing

The pen injector is being developed under a licensing agreement signed in January 2008 between the companies where Antares will supply a custom proprietary pen for two self-administered

Sander Deventer, Amsterdam Molecular Therapeutics’s (AMT) chief scientific officer and co-founder of the company, has been named CEO on an interim basis. The company has said that the

The study, at two academic departments of ophthalmology, is designed to assess the safety and efficacy of the Aquashunt and will enroll up to 20 patients with significantly

While performing heart bypass surgery, SPY-Q enables cardiac surgeons using Novadaq’s SPY imaging system to objectively measure increases in fluorescence by comparing pre- and post-bypass images, the company

The approval is based on data from two large, pivotal Phase III, multi-center, randomized, double-blind, placebo controlled trials, Phoenix 1 & 2, involving nearly 2,000 patients in whom

The non-exclusive agreement provides Biogenuix with the rights to distribute in India. Among the standardized RT-PCR (StaRT-PCR) based research molecular tools are kits for chronic myelogenous leukemia, lung

The drug candidate is an antimicrobial peptide named plectasin NZ2114 that targets the treatment of severe infections, such as pneumonia and septicaemia, caused by bacteria like Staphylococcus and